Healthcare of Ontario Pension Plan Trust Fund Boosts Stock Holdings in Kenvue Inc. $KVUE

Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 1,551.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,254,735 shares of the company’s stock after buying an additional 1,178,766 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned about 0.07% of Kenvue worth $21,644,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Elyxium Wealth LLC purchased a new stake in Kenvue during the fourth quarter valued at about $26,000. Physician Wealth Advisors Inc. boosted its position in Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after buying an additional 618 shares during the period. SBI Securities Co. Ltd. boosted its position in Kenvue by 82.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after buying an additional 1,027 shares during the period. Leonteq Securities AG purchased a new stake in Kenvue during the fourth quarter valued at about $45,000. Finally, Quarry LP purchased a new stake in Kenvue during the fourth quarter valued at about $76,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.59% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on KVUE. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Barclays dropped their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Weiss Ratings lowered shares of Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Finally, UBS Group dropped their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $19.33.

Kenvue Stock Performance

Kenvue stock opened at $18.25 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The firm has a 50-day moving average of $17.45 and a 200-day moving average of $17.55. The firm has a market cap of $35.03 billion, a P/E ratio of 21.47, a P/E/G ratio of 1.38 and a beta of 0.54. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $22.87.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. Kenvue’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.24 earnings per share. Sell-side analysts expect that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.